Delivered Revenue At the High End of the GuidanceImproved Gross Margin and Generated Strong Cash Flow From OperationsMARLBOROUGH, Mass., Feb.
Q3 2025 Earnings Call Transcript February 10, 2025 Columbus McKinnon Corporation misses on earnings expectations. Reported ...
Q1 2025 Earnings Call Transcript February 10, 2025 Arrowhead Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-1.39 EPS, expectations were $-0.42. Chris Anzalone: Thanks, Vince.